CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ACME Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ACME Laboratories Ltd
Court de la ACME
1/4, Kallayanpur, Mirpur Road
Phone: +880 280910513p:+880 280910513 DHAKA, 1207  Bangladesh Ticker: ACMELABACMELAB

Business Summary
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages form like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages form like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20246/30/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Number of Employees: 8,816 (As of 6/30/2023)
Outstanding Shares: 211,601,700 (As of 9/30/2024)
Stock Exchange: DSE
Fax Number: +880 258056299


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024